Literature DB >> 25313316

3-Cyano-3-aza-β-amino Acid Derivatives as Inhibitors of Human Cysteine Cathepsins.

Janina Schmitz1, Anna-Madeleine Beckmann2, Adela Dudic2, Tianwei Li2, Robert Sellier2, Ulrike Bartz3, Michael Gütschow2.   

Abstract

Nitrile-type inhibitors are known to interact with cysteine proteases in a covalent-reversible manner. The chemotype of 3-cyano-3-aza-β-amino acid derivatives was designed in which the N-cyano group is centrally arranged in the molecule to allow for interactions with the nonprimed and primed binding regions of the target enzymes. These compounds were evaluated as inhibitors of the human cysteine cathepsins K, S, B, and L. They exhibited slow-binding behavior and were found to be exceptionally potent, in particular toward cathepsin K, with second-order rate constants up to 52 900 × 10(3) M(-1) s(-1).

Entities:  

Keywords:  Cysteine proteases; human cathepsins; nitrile inhibitors; β-amino acids

Year:  2014        PMID: 25313316      PMCID: PMC4190633          DOI: 10.1021/ml500238q

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  32 in total

1.  Azadipeptide nitriles: highly potent and proteolytically stable inhibitors of papain-like cysteine proteases.

Authors:  Reik Löser; Maxim Frizler; Klaus Schilling; Michael Gütschow
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

Review 2.  Development of nitrile-based peptidic inhibitors of cysteine cathepsins.

Authors:  Maxim Frizler; Marit Stirnberg; Mihiret Tekeste Sisay; Michael Gütschow
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

3.  Induction of chirality: experimental evidence of atropisomerism in azapeptides.

Authors:  Philipp A Ottersbach; Gregor Schnakenburg; Michael Gütschow
Journal:  Chem Commun (Camb)       Date:  2012-05-02       Impact factor: 6.222

4.  Fluorescent nitrile-based inhibitors of cysteine cathepsins.

Authors:  Maxim Frizler; Matthias D Mertens; Michael Gütschow
Journal:  Bioorg Med Chem Lett       Date:  2012-10-03       Impact factor: 2.823

Review 5.  The behavior and significance of slow-binding enzyme inhibitors.

Authors:  J F Morrison; C T Walsh
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1988

6.  Small-molecule inhibitors of cathepsin L incorporating functionalized ring-fused molecular frameworks.

Authors:  Jiangli Song; Lindsay M Jones; Gustavo E Chavarria; Amanda K Charlton-Sevcik; Adam Jantz; Audra Johansen; Liela Bayeh; Victoria Soeung; Lindsey K Snyder; Shawn D Lade; David J Chaplin; Mary Lynn Trawick; Kevin G Pinney
Journal:  Bioorg Med Chem Lett       Date:  2012-12-20       Impact factor: 2.823

Review 7.  Cathepsin K: a unique collagenolytic cysteine peptidase.

Authors:  Marko Novinec; Brigita Lenarčič
Journal:  Biol Chem       Date:  2013-09       Impact factor: 3.915

8.  Synthesis and biochemical evaluation of thiochromanone thiosemicarbazone analogues as inhibitors of cathepsin L.

Authors:  Jiangli Song; Lindsay M Jones; G D Kishore Kumar; Elizabeth S Conner; Liela Bayeh; Gustavo E Chavarria; Amanda K Charlton-Sevcik; Shen-En Chen; David J Chaplin; Mary Lynn Trawick; Kevin G Pinney
Journal:  ACS Med Chem Lett       Date:  2012-04-18       Impact factor: 4.345

9.  Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells.

Authors:  Cristina Maria Costantino; Hidde L Ploegh; David A Hafler
Journal:  J Immunol       Date:  2009-06-24       Impact factor: 5.422

Review 10.  Antiresorptive drugs beyond bisphosphonates and selective oestrogen receptor modulators for the management of postmenopausal osteoporosis.

Authors:  J Y Reginster; A Neuprez; C Beaudart; M P Lecart; N Sarlet; D Bernard; S Disteche; O Bruyere
Journal:  Drugs Aging       Date:  2014-06       Impact factor: 3.923

View more
  5 in total

1.  Azanitrile Cathepsin K Inhibitors: Effects on Cell Toxicity, Osteoblast-Induced Mineralization and Osteoclast-Mediated Bone Resorption.

Authors:  Zhong-Yuan Ren; Irma Machuca-Gayet; Chantal Domenget; Rene Buchet; Yuqing Wu; Pierre Jurdic; Saida Mebarek
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

2.  Addition of 2-(ethylamino)acetonitrile group to nitroxoline results in significantly improved anti-tumor activity in vitro and in vivo.

Authors:  Ana Mitrović; Izidor Sosič; Špela Kos; Urša Lampreht Tratar; Barbara Breznik; Simona Kranjc; Bojana Mirković; Stanislav Gobec; Tamara Lah; Gregor Serša; Janko Kos
Journal:  Oncotarget       Date:  2017-07-17

3.  Design, synthesis, and in vitro evaluation of aza-peptide aldehydes and ketones as novel and selective protease inhibitors.

Authors:  Thomas S Corrigan; Leilani M Lotti Diaz; Sarah E Border; Steven C Ratigan; Kayla Q Kasper; Daniel Sojka; Pavla Fajtova; Conor R Caffrey; Guy S Salvesen; Craig A McElroy; Christopher M Hadad; Özlem Doğan Ekici
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

4.  Mapping the S1 and S1' subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents.

Authors:  Lorenzo Cianni; Carina Lemke; Erik Gilberg; Christian Feldmann; Fabiana Rosini; Fernanda Dos Reis Rocho; Jean F R Ribeiro; Daiane Y Tezuka; Carla D Lopes; Sérgio de Albuquerque; Jürgen Bajorath; Stefan Laufer; Andrei Leitão; Michael Gütschow; Carlos A Montanari
Journal:  PLoS Negl Trop Dis       Date:  2020-03-12

5.  Highly potent inhibitors of cathepsin K with a differently positioned cyanohydrazide warhead: structural analysis of binding mode to mature and zymogen-like enzymes.

Authors:  Jakub Benýšek; Michal Buša; Petra Rubešová; Jindřich Fanfrlík; Martin Lepšík; Jiří Brynda; Zuzana Matoušková; Ulrike Bartz; Martin Horn; Michael Gütschow; Michael Mareš
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.